Optilite Beta 2 Microglobulin Urine Kit LK043.L.OPT.ARecalls & reported problems
The Binding Site Group Limited · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
1 FDA recall record name this device's identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Mar 9, 2018Class IITerminated
The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
Z-1301-2018 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Other System, Test, Beta-2-Microglobulin Immunological devices
- Atellica CH B2M 11097635Siemens Healthcare Diagnostics Inc. · System, test, beta-2-microglobulin immunological2 recalls0 reports
- Tina-quant ß2-Microglobulin 08047430190Roche Diagnostics GmbH · System, test, beta-2-microglobulin immunological1 report
- Tinaquant 2Microglobulin 11660551216Roche Diagnostics GmbH · SYSTEM, TEST, BETA-2-MICROGLOBULIN IMMUNOLOGICAL1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page